pharma · Gout · Asthma
Sunshine Guojian Pharmaceutical
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Sunshine Guojian Pharmaceutical clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- FORT LAUDERDALE, FL, CN
- Programs
- 165
- Drugs
- 80
- Patents
- 121
Sunshine Guojian Pharmaceutical projects
5 ClinicalTrials.gov programs sponsored by Sunshine Guojian Pharmaceutical.
Sunshine Guojian Pharmaceutical has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Ceftolozane/tazobactam
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Bronchiectasis
1 trial -
EPIAO®
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Renal Anaemia
1 trial -
Sulforaphane
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
HIV Infections
1 trial -
TPO
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
ITP
1 trial -
rhTPO
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Previously Treated Primary Immune Thrombocytopenia
1 trial
Frequently asked questions
How many clinical projects does Sunshine Guojian Pharmaceutical have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.